PyroGenesis Announces Closing of the First Tranche of the Second Unit Group of the Non-Brokered Private Placement for Approximately $822,000

(TSX:PYR),(OTC US:PYRGF),(Other OTC:PYRGF),(Frankfurt:8PY1), MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes & engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that further to its press release dated October 1, 2025, the Company has completed the […]

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

(NasdaqGM:ADMA), RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report third quarter 2025 financial results on November 5, 2025, after the U.S.

Chicago Atlantic BDC, Inc. Announces Third Quarter 2025 Financial Results Conference Call

(NasdaqGM:LIEN), NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial results for the third quarter ended September 30, 2025. The Company plans to release

The Chefs’ Warehouse Reports Third Quarter 2025 Financial Results

(NASDAQ:CHEF), RIDGEFIELD, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its third quarter ended September 26, 2025. Financial highlights for the third quarter of 2025:

Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund

(TSX-V:CNVI),(OTC US:CNVIF),(Other OTC:CNVIF), TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, is pleased to announce that it has entered into an agreement with the Province of

Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025

(NASDAQ:ARVN), NEW HAVEN, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from the third quarter of 2025 and provide a corporate update during a live webcast on Wednesday, November

National Property REIT Corp., a Prospect Capital Corporation Portfolio Company, Exits Crown Point Property with a 19.1% IRR and 2.6x Cash-on-Cash Multiple

(NASDAQ:PSEC), NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — National Property REIT Corp. (“NPRC”), a wholly owned portfolio company of Prospect Capital Corporation (NASDAQ: PSEC), today announced the sale of Crown Point Apartments (“Crown Point”), a multifamily property in Danbury, Connecticut, for $151.75 million, achieving a 19.1% internal rate of return and a 2.6x cash-on-cash

UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session

— UCB will showcase 18 abstracts, including an oral presentation, demonstrating continued commitment to advancing targeted treatments for generalized myasthenia gravis (gMG). — Presentations include new post hoc analyses considering corticosteroid dose tapering during treatment with RYSTIGGO® (rozanolixizumab-noli)1 and the impact of ZILBRYSQ® (zilucoplan) on Myasthenia Gravis Quality of Life 15-revised (MG-QoL15r) items.2 UCB (Euronext

MedMark Treatment Centers Enhances Telehealth Services in Pennsylvania

WASHINGTON, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) — MedMark Treatment Centers, a leading provider of outpatient care for opioid use disorder, announced the appointment of Angela McClenathan, MSN, NP-BC, as its new dedicated Telehealth Nurse Practitioner. The new provider will serve MedMark's five Pennsylvania centers in Blairsville, Greensburg, Lemont Furnace, Perryopolis, and Washington. The addition

TradePending and DriveCentric Announce Integration Partnership

CHAPEL HILL, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) — TradePending, a provider of customer engagement solutions for auto dealerships, today announced a new partnership with DriveCentric, integrating DriveCentric's customer relationship management (CRM) system with TradePending's AutoBio and Video customer engagement solutions. The combination enables dealership sales teams to streamline their sales cycle, by providing a

Scroll to Top